ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

November 9, 2001

Pesticides Not Linked To High Rates Of Breast Cancer.

May 18, 2001

In Brief: Gallo Signs Agreement With Univ. of Maryland; Donor Gives $5 Million To San Diego Center

May 26, 1995